Stocktoria
Earth Science Tech, Inc. ETST
Earth Science Tech, Inc. (ETST) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2026 revenue was $35.7M at a 10.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: 0.14 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1961 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ETST | Earth Science Tech, Inc. | 4/9 | — | 12.7 | +7.8% |
| VRCA | Verrica Pharmaceuticals Inc. | 5/9 | -19.42 | — | — |
| SBFM | Sunshine Biopharma Inc. | 4/9 | -1.63 | — | +4.1% |
| BGM | BGM Group Ltd. | 5/9 | 7.99 | — | +51.1% |
| ZOMDF | Zomedica Corp. | 3/9 | 1.07 | — | +17.4% |
| VSTM | Verastem, Inc. | 4/9 | -15.71 | — | +209.1% |
| FHTX | Foghorn Therapeutics Inc. | 1/9 | -10.28 | — | +36.8% |
About Earth Science Tech, Inc.
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in vertically integrated healthcare platforms that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment. It is also involved in investments in real estate and asset management activities, and consumer products business. It also operates multi-state sterile non-sterile compounding for specialized therapies through RxCompoundStore.com; mister meds sterile and hazardous compounding center under the Mister Meds name; frictionless asynchronous consults funneling to licensed pharmacies; under the Peaks Curative brand name; virtual care brand for home-based therapies under the DOConsultations brand name; and brick-and-mortar healthcare facility under the Villas Health Care brand name. In addition, it is involved in the development, asset management, and financing under the Avenvi brand name; and provides direct-to-consumer retail under the MagneChef brand name. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
FAQ
Is ETST financially healthy?
Earth Science Tech, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does ETST pay a dividend?
No, Earth Science Tech, Inc. does not currently pay a dividend.
How profitable is ETST?
In FY2026, Earth Science Tech, Inc. had a net margin of 10.2% and a return on equity of 51.6%.
What is ETST's P/E ratio?
Earth Science Tech, Inc.'s trailing price-to-earnings (P/E) ratio is about 12.7×, based on its latest annual earnings.
What is the analyst price target for ETST?
The average Wall-Street price target for Earth Science Tech, Inc. is $1.00, about 910.1% above the recent price, from 1 analysts (consensus: strong buy).
Is ETST a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Earth Science Tech, Inc.: a Piotroski F-score of 4/9, a P/E of about 12.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.